Half of pharma and biotech companies using AI and big data

A survey conducted by ICON has found sentiment towards artificial intelligence (AI) and digital tools in the clinical research sector is positive, with 49% of pharmaceutical and biotechnology companies employing AI and Big Data in their programs. This represents a 10% increase from the number recorded in ICON’s 2019 survey.